Clinical Trials Browser

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Cardiotoxicity

NCT02663232 2023-07-03

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Completed

264 enrolled 20 charts

Dermatologic

Melanoma, Neoplasms

NCT00793169 2021-12-06

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery

Completed

19 enrolled 4 charts

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT02296164 2020-03-04

PROVe

Completed

300 enrolled 7 charts

DermatologicLymphoid

Mycosis Fungoides, Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT03693937 2019-07-05

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)

Completed

776 enrolled 5 charts

Dermatologic

Non-melanoma Skin Cancer

NCT01551082 2016-12-12

Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Terminated

12 enrolled 3 charts

DermatologicThoracic

Lung Neoplasms, Pneumothorax, Subcutaneous Emphysema

NCT01806961 2016-08-03

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Terminated

16 enrolled 4 charts

Dermatologic

Keratosis, Actinic

NCT01744860 2016-03-28

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

Completed

420 enrolled 30 charts

Dermatologic

Melanoma

NCT00749684 2015-10-19

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

Completed

138 enrolled 6 charts

Dermatologic

Melanoma

NCT00723710 2015-08-26

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Completed

299 enrolled 5 charts

Dermatologic

Melanoma

NCT01387581 2014-11-14

Does the Aid of MelaFind Affect Clinical Management Decisions

Completed

227 enrolled 9 charts

Dermatologic

Melanoma

NCT01480219 2013-03-11

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Completed

467 enrolled 6 charts

Dermatologic

Non-Melanoma Skin Carcinoma

NCT00836342 2012-07-25

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Completed

81 enrolled 6 charts

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Neoplasms

NCT01011153 2012-02-14

Survey Study - Sensitivity Comparison Between MelaFind and Physician Group

Completed

241 enrolled 7 charts

Dermatologic

Melanoma

NCT00668733 2010-07-20

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

Completed

179 enrolled 6 charts

Dermatologic

Skin Diseases, Keratosis, Actinic

Clinical Trials

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

LEGIT_MC_EVCDA

Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection

OCEANMIST

A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

AI-DSMM

A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

Imaging FDG Flare in Melanoma

PROAK

Utility of Novel BRAF Test for Melanoma

VircapSeq Virus Detection in Sézary Syndrome

VISION

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

OASIS

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery

PROVe

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)

Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Does the Aid of MelaFind Affect Clinical Management Decisions

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Survey Study - Sensitivity Comparison Between MelaFind and Physician Group

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year